Leila Husseini

417 total citations
9 papers, 134 citations indexed

About

Leila Husseini is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Leila Husseini has authored 9 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 4 papers in Neurology and 4 papers in Immunology. Recurrent topics in Leila Husseini's work include Multiple Sclerosis Research Studies (6 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Peripheral Neuropathies and Disorders (2 papers). Leila Husseini is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Peripheral Neuropathies and Disorders (2 papers). Leila Husseini collaborates with scholars based in Germany, Slovakia and Austria. Leila Husseini's co-authors include Martin S. Weber, Hans‐Peter Hartung, Bernd C. Kieseier, Erasmia Broussalis, Verena I. Leussink, Clemens Warnke, Guido Reifenberger, Andreas Saleh, Wolfgang Brück and Silke Häusser‐Kinzel and has published in prestigious journals such as Trends in Neurosciences, Journal of Neuroinflammation and Pharmaceuticals.

In The Last Decade

Leila Husseini

9 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila Husseini Germany 6 75 50 30 27 19 9 134
Katrin Straßburger-Krogias Germany 7 54 0.7× 41 0.8× 7 0.2× 11 0.4× 5 0.3× 9 118
Haley C. Cropper United States 7 15 0.2× 18 0.4× 13 0.4× 21 0.8× 6 0.3× 12 145
Dario Cocito Italy 7 14 0.2× 154 3.1× 17 0.6× 18 0.7× 5 0.3× 9 205
Jinjie Zhong China 10 77 1.0× 15 0.3× 8 0.3× 28 1.0× 16 0.8× 15 279
Jennifer Nicholas United Kingdom 2 56 0.7× 21 0.4× 5 0.2× 18 0.7× 2 0.1× 3 110
Emanuela Rotondo Italy 8 13 0.2× 84 1.7× 8 0.3× 14 0.5× 12 0.6× 16 244
Cristina Íñiguez Spain 9 108 1.4× 80 1.6× 6 0.2× 11 0.4× 7 0.4× 18 241
Nina Wagner Germany 3 25 0.3× 29 0.6× 9 0.3× 3 0.1× 7 0.4× 4 160
Federico Montini Italy 7 61 0.8× 113 2.3× 2 0.1× 12 0.4× 3 0.2× 14 194
Maria Malentacchi Italy 9 101 1.3× 74 1.5× 2 0.1× 20 0.7× 2 0.1× 17 182

Countries citing papers authored by Leila Husseini

Since Specialization
Citations

This map shows the geographic impact of Leila Husseini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Husseini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Husseini more than expected).

Fields of papers citing papers by Leila Husseini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Husseini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Husseini. The network helps show where Leila Husseini may publish in the future.

Co-authorship network of co-authors of Leila Husseini

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Husseini. A scholar is included among the top collaborators of Leila Husseini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Husseini. Leila Husseini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Husseini, Leila, Niels Kruse, Stefan Nessler, et al.. (2024). Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 11(5). e200279–e200279. 5 indexed citations
2.
Husseini, Leila, et al.. (2023). Toward identifying key mechanisms of progression in multiple sclerosis. Trends in Neurosciences. 47(1). 58–70. 20 indexed citations
3.
Husseini, Leila, et al.. (2021). B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders. Pharmaceuticals. 14(1). 37–37. 6 indexed citations
4.
Pellkofer, Hannah, et al.. (2019). Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients. Journal of Neuroinflammation. 16(1). 228–228. 30 indexed citations
5.
Husseini, Leila, Andreas Saleh, Guido Reifenberger, Hans‐Peter Hartung, & Bernd C. Kieseier. (2012). Inflammatory Demyelinating Brain Lesions Heralding Primary CNS Lymphoma. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 39(1). 6–10. 27 indexed citations
6.
Albrecht, Philipp, Mark Stettner, Leila Husseini, et al.. (2012). An emboligenic pulmonary abscess leading to ischemic stroke and secondary brain abscess. BMC Neurology. 12(1). 133–133. 6 indexed citations
7.
Leussink, Verena I., Leila Husseini, Clemens Warnke, et al.. (2012). Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Therapeutic Advances in Neurological Disorders. 5(5). 255–266. 35 indexed citations
8.
Husseini, Leila, Verena I. Leussink, Clemens Warnke, H.‐P. Hartung, & B. C. Kieseier. (2011). Cannabinoide zur symptomatischen Therapie der Multiplen Sklerose. Der Nervenarzt. 83(6). 695–704. 2 indexed citations
9.
Husseini, Leila, et al.. (2010). 4-Aminopyridin (Fampridin). Der Nervenarzt. 81(2). 203–211. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026